Summary
Supplement F: Laboratory Guidance
Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2/3
printer friendly version [2 pages]
Goals
- Provide the public health community with ready access to high-quality SARS-CoV diagnostics.
- Ensure that SARS-CoV laboratory diagnostics are used safely and appropriately and that results are interpreted appropriately.
Key concepts
- Efficient SARS-CoV diagnostic assays have been developed, but they frequently do not provide a definitive diagnosis early in illness.
- Although the sensitivity of current assays probably cannot be improved significantly, changes in the type, quality, and processing of specimens may improve the ability to detect SARS-CoV infection in patients.
- The majority of SARS-like illnesses will be caused by other respiratory pathogens; rapid and accurate diagnosis of these infections will make it easier to manage community anxiety about SARS-like illnesses.
- The possibility of false-positive and false-negative results with both PCR and serologic assays should always be considered when interpreting results; clear strategies to minimize such possibilities and to confirm test results are essential.
Priority activities
- Improve the ability to detect SARS-CoV infection by optimizing the selection and timing of specimen collection and processing.
- Provide SARS-CoV assays for RT-PCR testing to Laboratory Response Network (LRN) laboratories and for serologic testing to state public health laboratories.
- Distribute proficiency panels and questionnaires to participating laboratories to determine the ability of laboratories to provide valid SARS-CoV diagnostics.
- Provide guidance on laboratory safety for SARS-CoV and other respiratory diagnostic testing and for possible SARS-CoV-containing specimens submitted for other tests.
- Provide guidance for interpreting test results, taking into account the potential for false-positive and false-negative results and the availability of applicable clinical and epidemiologic information.
- Identify surge capacity for laboratory testing in the event of a large SARS outbreak.
Related Pages
- Summary
- I. Rationale and Goals
- II. Lessons Learned
- III. Diagnostic Assays
- IV. CDC's Laboratory Diagnostics Plan
- Appendix F1: Proficiency Testing for Public Health Laboratories Performing SARS-CoV EIA and RT-PCR Diagnostics
- Appendix F2: SARS-CoV Specimen Testing Guidelines: RT-PCR and Serology
- Appendix F3: Guidelines for Clinicians: The Consent Process for SARS-CoV RT-PCR and EIA Testing at CDC and Public Health Laboratories
- Appendix F4: Guidelines for Collecting Specimens from Potential SARS Patients
- Appendix F5: Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with SARS-CoV
- Appendix F6: Guidelines for Medical Surveillance of Laboratory Personnel Working with SARS-CoV
- Appendix F7: Fact Sheet for Clinicians: Interpreting SARS-CoV Test Results from CDC and Other Public Health Laboratories
- Appendix F8: Guidelines for Laboratory Diagnosis of SARS-CoV Infection
- Page last reviewed: May 3, 2005
- Page last updated: May 3, 2005
- Content source: